Breed of mice created for leukemia study

Aug 22, 2006

A study by U.S. cancer scientists at Ohio State University shows a new strain of mice offers the first real animal model for an incurable chronic leukemia.

The mouse, called the TCL-1 transgenic mouse, develops a malignancy that closely mimics chronic lymphocytic leukemia, or CLL. The lack of such an animal model has previously hampered the development of treatments for CLL, as well as research into its causes and the changes that drive drug resistance.

"This mouse strain shares many of the molecular and genetic features of human CLL, responds to drugs typically used to treat the disease and develops drug resistance that renders treatment ineffective, as often happens in CLL patients," said principal investigator John Byrd, a professor of internal medicine.

Byrd is a specialist in CLL at Ohio State University's Arthur James Cancer Hospital and Richard Solove Research Institute.

"The strain should be extremely valuable for the development and testing of both conventional drugs and those aimed at molecular targets for CLL," he said.

The findings are published in the Aug. 15 issue of the journal Blood.

Copyright 2006 by United Press International

Explore further: Salmonella and Campylobacter show significant levels of resistance to common antimicrobials in humans and animals

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Finding psychological insights through social media

17 hours ago

Social media has opened up a new digital world for psychology research. Four researchers will be discussing new methods of language analysis, and how social media can be leveraged to study personality, mental and physical ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.